Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- February 2013
- DOI:
- 10.1371/journal.pone.0055438
- Bibcode:
- 2013PLoSO...855438L